167 related articles for article (PubMed ID: 34943994)
1. CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34
Ostrovsky O; Beider K; Morgulis Y; Bloom N; Cid-Arregui A; Shimoni A; Vlodavsky I; Nagler A
Cells; 2021 Dec; 10(12):. PubMed ID: 34943994
[TBL] [Abstract][Full Text] [Related]
2. The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease.
Ostrovsky O; Baryakh P; Morgulis Y; Mayorov M; Bloom N; Beider K; Shimoni A; Vlodavsky I; Nagler A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685503
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors.
Ostrovsky O; Shimoni A; Rand A; Vlodavsky I; Nagler A
Blood; 2010 Mar; 115(11):2319-28. PubMed ID: 20075159
[TBL] [Abstract][Full Text] [Related]
4. Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP.
Ostrovsky O; Shimoni A; Baryakh P; Morgulis Y; Mayorov M; Beider K; Shteingauz A; Ilan N; Vlodavsky I; Nagler A
J Leukoc Biol; 2014 Apr; 95(4):677-88. PubMed ID: 24319286
[TBL] [Abstract][Full Text] [Related]
5. Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant.
Metafuni E; Giammarco S; Bellesi S; Rossi M; Minnella G; Limongiello MA; Valentini CG; Teofili L; Sica S; Chiusolo P
Int J Lab Hematol; 2023 Dec; 45(6):935-944. PubMed ID: 37646104
[TBL] [Abstract][Full Text] [Related]
6. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation.
Ostrovsky O; Korostishevsky M; Shafat I; Mayorov M; Ilan N; Vlodavsky I; Nagler A
J Leukoc Biol; 2009 Aug; 86(2):445-55. PubMed ID: 19406828
[TBL] [Abstract][Full Text] [Related]
8. Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma.
Ostrovsky O; Beider K; Magen H; Leiba M; Sanderson RD; Vlodavsky I; Nagler A
Cells; 2023 Mar; 12(6):. PubMed ID: 36980254
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of HPSE Gene SNPs Function: From Normal Processes to Inflammation, Cancerogenesis and Tumor Progression.
Ostrovsky O; Vlodavsky I; Nagler A
Adv Exp Med Biol; 2020; 1221():231-249. PubMed ID: 32274712
[TBL] [Abstract][Full Text] [Related]
10. Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies.
Ostrovsky O; Grushchenko-Polaq AH; Beider K; Mayorov M; Canaani J; Shimoni A; Vlodavsky I; Nagler A
Oncogenesis; 2018 Jun; 7(6):51. PubMed ID: 29955035
[TBL] [Abstract][Full Text] [Related]
11. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
[TBL] [Abstract][Full Text] [Related]
12. Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
Beloki L; Ramírez N; Olavarría E; Samuel ER; Lowdell MW
Cytotherapy; 2014 Oct; 16(10):1390-408. PubMed ID: 24954783
[TBL] [Abstract][Full Text] [Related]
13. Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer.
Cao H; Yang S; Yu X; Xi M
Mol Genet Genomic Med; 2020 Oct; 8(10):e1257. PubMed ID: 32869952
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.
Smith MS; Goldman DC; Bailey AS; Pfaffle DL; Kreklywich CN; Spencer DB; Othieno FA; Streblow DN; Garcia JV; Fleming WH; Nelson JA
Cell Host Microbe; 2010 Sep; 8(3):284-91. PubMed ID: 20833379
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J
Ann Hematol; 2019 Jul; 98(7):1755-1763. PubMed ID: 30993417
[TBL] [Abstract][Full Text] [Related]
17. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
Cantoni N; Hirsch HH; Khanna N; Gerull S; Buser A; Bucher C; Halter J; Heim D; Tichelli A; Gratwohl A; Stern M
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1309-14. PubMed ID: 20353832
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
